Proteinase K Market Report 2026

Proteinase K Market Overview

• Proteinase K market size has reached to $5.29 billion in 2025 • Expected to grow to $8.91 billion in 2030 at a compound annual growth rate (CAGR) of 11% • Growth Driver: Proteinase K Market Surges With Increasing Prevalence Of Chronic Diseases • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Proteinase K Market?

Proteinase K is a proteolytic enzyme (a serine protease) naturally found in the mold Tritirachium album that can inactivate protein contaminants in prepared samples. Proteinase K is used during the process of DNA extraction to help digest the contaminating proteins that are present. The main proteinase k form types are lyophilized powder form and liquid form. Lyophilized powder form refers to the process by which a product is obtained after water is removed and the product is frozen and placed under a vacuum. The various therapeutic areas are infectious diseases, diabetes; oncology, cardiology, nephrology, autoimmune diseases, neurology, and others applied in isolation and purification of genomic DNA and RNA, in situ hybridization, mitochondria isolation, and enzyme removal. the end uses are contract research organizations, academic institutes, biotechnology companies, and diagnostics laboratories.

What Is The Proteinase K Market Growth Forecast?

The proteinase k market size is expected to see rapid growth in the next few years. It will grow to $8.91 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to increasing investments in precision medicine, rising adoption of advanced diagnostic testing, expansion of biotechnology research pipelines, growing demand for automation-compatible reagents, increasing focus on reproducible research outcomes. Major trends in the forecast period include increasing demand for high-purity enzymes, rising use in dna and rna extraction protocols, growing adoption in molecular diagnostics, expansion of genomics research activities, enhanced focus on sample preparation accuracy.

Global Proteinase K Market Segmentation

1) By Type: Lyophilized Powder Form, Liquid Form 2) By Application: Isolation And Purification Of Genomic DNA And RNA, In Situ Hybridization, Mitochondria Isolation, Enzyme Removal 3) By End-Use: Contract Research Organization, Academic Institutes, Biotechnology Companies, Diagnostic Laboratories Subsegments: 1) By Lyophilized Powder Form: High Purity Lyophilized Powder, Standard Grade Lyophilized Powder 2) By Liquid Form: Ready-To-Use Liquid, Concentrated Liquid Solutions

What Are The Drivers Of The Proteinase K Market?

An increasing prevalence of chronic diseases is expected to propel the growth of the proteinase K market going forward. Chronic disease is a condition or illness that lasts more than a year and requires ongoing medical treatment. Proteinase K is used in chronic diseases in a preventative or therapeutic role to extract and isolate the DNA (Deoxyribonucleic Acid) and RNA (Ribonucleic Acid) of viruses that cause various chronic diseases. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least 1 chronic condition would increase to 142.66 million by 2050. Therefore, an increasing prevalence of chronic diseases will drive the proteinase K industry. The increasing incidence of infectious diseases such as tuberculosis diseases is expected to propel the growth of the proteinase K market going forward. Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis, a bacterium that primarily affects the lungs but can also impact other parts of the body. Proteinase K is utilized in TB research for the extraction and isolation of DNA (Deoxyribonucleic Acid) and RNA (Ribonucleic Acid) from the Mycobacterium tuberculosis bacterium. For instance, in February 2024, according to the GOV.UK, a UK-based government department, cases of tuberculosis (TB) in England increased by 10.7% in 2023, rising from 4,380 in 2022 to 4,850. Therefore, the increasing incidence of infectious diseases such as tuberculosis diseases will drive the proteinase K industry.

What Are The Drivers Of The Proteinase K Market?

An increasing prevalence of chronic diseases is expected to propel the growth of the proteinase K market going forward. Chronic disease is a condition or illness that lasts more than a year and requires ongoing medical treatment. Proteinase K is used in chronic diseases in a preventative or therapeutic role to extract and isolate the DNA (Deoxyribonucleic Acid) and RNA (Ribonucleic Acid) of viruses that cause various chronic diseases. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least 1 chronic condition would increase to 142.66 million by 2050. Therefore, an increasing prevalence of chronic diseases will drive the proteinase K industry. The increasing incidence of infectious diseases such as tuberculosis diseases is expected to propel the growth of the proteinase K market going forward. Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis, a bacterium that primarily affects the lungs but can also impact other parts of the body. Proteinase K is utilized in TB research for the extraction and isolation of DNA (Deoxyribonucleic Acid) and RNA (Ribonucleic Acid) from the Mycobacterium tuberculosis bacterium. For instance, in February 2024, according to the GOV.UK, a UK-based government department, cases of tuberculosis (TB) in England increased by 10.7% in 2023, rising from 4,380 in 2022 to 4,850. Therefore, the increasing incidence of infectious diseases such as tuberculosis diseases will drive the proteinase K industry.

What Are Latest Mergers And Acquisitions In The Proteinase K Market?

In January 2023, Lighthouse Pharma, a US-based biopharmaceutical company, acquired the small molecule proteinase inhibitor portfolio from Quince Therapeutics Inc. for an undisclosed amount. The acquisition will assist Lighthouse in continuing the development of gingipain inhibitors for dementia and other disorders and also provide innovative treatments for patients. Quince Therapeutics Inc. is a US-based biotechnology company that deals with various products, such as proteinase inhibitors.

Regional Insights

North America was the largest region in the global proteinase K market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global proteinase k market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Proteinase K Market?

The proteinase K market consists of sales of acid proteinase, neutral proteinase, and alkaline proteinase. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Proteinase K Market Report 2026?

The proteinase k market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the proteinase k industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.